Delhi HC: AIIMS to resume dispensation of medicines from pharmacy without delay

The Delhi High Court has asked the All India Institute of Medical Sciences (AIIMS) to make sure that dispensation of medicines from its pharmacy which was functioning limited due to the lockdown to resume without any delay.

Delhi High Court order came on a PIL which stated that non-coronavirus patients who had come for treatment at AIIMS from different ststaion are unable to get medication from the hospital’s pharmacy due to the lockdown.
Rachna Malik, the petitioner also claimed that patients were there was no endorsement on their OPD cards permitting dispensation of medicines as the OPD of AIIMS was closed due to COVID-19 lockdown.

In reply, AIIMS answered the court that its pharmacy has been made fully functional since May 6 and it operates from 10.00 am to 5.00 pm. AIIMS would devise a methodology to enable patients to obtain medicines from the pharmacy, in all such cases, where the medication prescribed requires continuous administration.
A bench of justices Vipin Sanghi and Rajnish Bhatnagar asked AIIMS on the particular issue and asked to file a compliance report before May 14, on the next date of hearing.

  • Related Posts

    Excellence of Accredited Hospitals to be judged on how Friendly they are with Patients

    Patients for Patient Safety Foundation (PFPSF) Partners with CAHO to RollOut an Excellence Program New Delhi: Thanks to some well-meaning organizations, patients are going to be lord of all they…

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    BMJ Research Forum all set to mull over in Delhi on September 5 New Delhi: Research in healthcare in India is a dime a dozen. But the real question that…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

    Medicines that cure Us are making Our Environment Sick

    Medicines that cure Us are making Our Environment Sick